Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PDE2A antisense RNA 1 (PDE2A-AS1) is a long non-coding RNA gene situated antisense to the *PDE2A* gene locus[5]. Unlike the protein-coding PDE2A, this gene produces a non-coding RNA that likely regulates the expression of PDE2A or nearby genes at the RNA level. There is no evidence to date that PDE2A-AS1 encodes a protein or acts as a direct therapeutic target, receptor, enzyme, transporter, or similar druggable entity. Its principal characterized function is presumed regulatory, involving modulation of gene expression, but detailed mechanistic or disease associations are not established in the core biomedical databases[5]. *PDE2A-AS1* is distinct from the protein-coding phosphodiesterase 2A (PDE2A) gene; the latter encodes an important cyclic nucleotide phosphodiesterase, while *PDE2A-AS1* is a non-coding RNA[5]. There is no reported drug or small molecule that directly targets PDE2A-AS1, nor are there established safety concerns or biomarker uses for this lncRNA. If you require details on the protein-coding *PDE2A* target rather than its antisense non-coding RNA, please clarify, as the biological roles and druggability profiles are fundamentally different.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PDE2A antisense RNA 1 (PDE2A-AS1).